GSK will launch the first tetravalent flu vaccine ‘Fluarix Tetra’
GSK announced that it would launch the first domestic tetravalent influenza vaccine ‘Fluarix Tetra’.
Fluatrix Tetra includes 2 types of virus type A (A/H1N1, A.H3N2) and 2 types of virus type B (B-Victoria, B-Yamagata), causing influenza for both infants over 3 and adults.
Including Korea, it i...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
